(Q57580751)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

The triple-negative subtype: new ideas for the poorest prognosis breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

Aron Goldhirsch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute Monographs

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

108-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Triple-negative breast cancer: risk factors to potential targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Pattern of metastatic spread in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

The genetics of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Weekly paclitaxel in the adjuvant treatment of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGR038

10.1093/JNCIMONOGRAPHS/LGR038

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22043054%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference